New Jersey drugmaker to cut 69 opioid sales jobs

Daiichi Sankyo, which has a U.S. headquarters in Basking Ridge, N.J., will lay off 69 members of its opioid pain medication sales force by October, according to ROI-NJ.com.

The company will eliminate its sales force in the U.S. serving the MorphaBond ER product, an extended relief morphine medication. The company will continue to sell the drug, but it will do so without a dedicated sales force. 

"We are making this change to focus our resources and energy on our oncology pipeline and our iron business," an unnamed spokesperson told ROI-NJ. "We are proud and thankful of the effort by our field sales teams and thank them for their dedication to patients and the providers who care for them."

More articles on pharmacy:
CMS to cover CAR-T therapy nationwide
Colombia fines Pfizer $25K for drug price inflation
Jefferson Healthcare opens retail specialty pharmacy

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months